Education
About Us
Working with TipRanks
Follow Us
Lotus Pharmaceuticals (LTUS)
:LTUS
LTUS Stock Chart & Stats
Day’s RangeN/A
52-Week Range― - ―
Previous CloseN/A
Volume1.00
Average Volume (3M)27.89K
Market Cap
$172.46K
Enterprise ValueN/A
Total Cash (Recent Filing)$419.00
Total Debt (Recent Filing)$123.43K
Price to Earnings (P/E)―
Beta-3.60
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.00
Shares Outstanding27,816,000
10 Day Avg. Volume538
30 Day Avg. Volume27,891
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
―
Mutual Funds
0.14% Other Institutional Investors
99.86% Public Companies and
Individual Investors
LTUS FAQ
What was Lotus Pharmaceuticals ’s price range in the past 12 months?
Currently, no data Available
What is Lotus Pharmaceuticals ’s market cap?
Lotus Pharmaceuticals ’s market cap is $172.46K.
When is Lotus Pharmaceuticals ’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Lotus Pharmaceuticals ’s earnings last quarter?
Currently, no data Available
Is Lotus Pharmaceuticals overvalued?
According to Wall Street analysts Lotus Pharmaceuticals ’s price is currently Overvalued.
Does Lotus Pharmaceuticals pay dividends?
Lotus Pharmaceuticals does not currently pay dividends.
What is Lotus Pharmaceuticals ’s EPS estimate?
Lotus Pharmaceuticals ’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Lotus Pharmaceuticals have?
Lotus Pharmaceuticals has 27,816,000 shares outstanding.
What happened to Lotus Pharmaceuticals ’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Lotus Pharmaceuticals ?
Currently, no hedge funds are holding shares in LTUS
Company Description
Lotus Pharmaceuticals
Lotus Pharmaceuticals, Inc. does not have significant operations. Previously, it was engaged in the development, manufacture, and sale of pharmaceuticals in the People's Republic of China. The company is based in Nashville, Tennessee.